跳至主要内容
临床试验/2024-515308-38-00
2024-515308-38-00招募中3 期

COURAGE - Corticosteroid in acute urticaria in emergency department

Assistance Publique Hopitaux De Paris, Assistance Publique Hopitaux De Paris5 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2024年8月13日最近更新:
相关药物

试验速览

阶段
3 期
状态
招募中
入组人数
240
试验地点
5
主要终点
7-Days Urticaria Activity Score (UAS 7) at day 7

研究概览

简要总结

To demonstrate the non-inferiority of the efficacy of a single antihistamine in comparaison with an association of antihistamine and corticosteroid in the treatment of acute urticaria in emergency departments

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65+ years(18-64 Years, 65+ Years)
接受健康志愿者

入选标准

  • Age > 18 years
  • Acute urticaria with angioedema without laryngeal edema
  • Obtain patient’s consent
  • Social security affiliation

排除标准

  • Pregnancy or breastfeeding
  • Atopic dermatitis
  • Bullous pemphigoid
  • Acute exanthematous pustulosis
  • Diabetes mellitus
  • Gastrointestinal ulcer
  • Refusal to participate
  • Known allergy to the study drugs or formulation ingredients
  • Hypersensitivity to lactose
  • Known Renal failure defined by creatinine clearance < 10 mL/min or cardiac failure defined by ejection fraction < 40%
  • Acute hives with anaphylaxis
  • Hypersensitivity to active substance, to cetirizine, to hydroxyzine and to pipérazine and excipients
  • Contre-indication to corticotherapy: o Any live vaccine o Psychotic states still uncontrolled by treatment limiting the participant's compliance with the research o Some viruses in evolution (including hepatitis, herpes, chicken pox, shingles). o Any infectious condition
  • Bradykinin angioedema
  • Angioedema without urticaria (hives)
  • Laryngeal edema with urticaria (hives)
  • Corticosteroid administration in the previous 5 days visiting the emergency department
  • Antihistamines greater than 1 tablet per day in the previous 5 days visiting the ED
  • Other treatment for urticaria : omalizumab, montelukast, ciclosporine A
  • Chronic urticaria before acute urticaria diagnosis

结局指标

主要结局

7-Days Urticaria Activity Score (UAS 7) at day 7

7-Days Urticaria Activity Score (UAS 7) at day 7

次要结局

未报告次要终点

研究者

申办方类型
Hospital/Clinic/Other health care facility, Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Coordinating Investigator

Scientific

Assistance Publique Hopitaux De Paris

研究点 (5)

Loading locations...

相似试验